Background: Voriconazole is widely used in the treatment of life-threatening invasive fungal infections (IFIs). The use of voriconazole is problematic due to its highly variable pharmacokinetics and narrow therapeutic index which complicate dosage selection and adjustment; few population pharmacokinetic data are available. Aim: This study aimed to develop a voriconazole population model incorporating data from […]
February 4, 2013
Authors Michael Dolton (1), Gerd Mikus (2), Johanna Weiss (2), John Ray (3), Andrew McLachlan (1,4).
Affiliations 1. Faculty of Pharmacy, University of Sydney, Camperdown NSW, 2. Clinical Pharmacology Study Centre, Heidelberg University Hospital, Heidelberg Germany, 3. SydPath, St Vincent’s Hospital, Darlinghurst NSW, 4. Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord NSW.
Presentation type Poster
Presenters Michael Dolton